EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics

Harshita Tiwari, Nilesh Rai iD, Swati Singh, Priyamvada Gupta, Ashish Verma, Akhilesh Kumar Singh, Kajal, Prafull Salvi iD, Santosh Kumar Singh iD, Vibhav Gautam iD

Bioengineering · 25.06.2023 · 10 (7) · 760

DOI: 10.3390/bioengineering10070760 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 25.06.2023. Verfasst von Harshita Tiwari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board, University Grants Commission, Banaras Hindu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nano-oncology is a branch of biomedical research and engineering that focuses on using nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively employed in the field of oncology because of their minute size and ultra-specificity. A wide range of nanocarriers, such as dendrimers, micelles, PEGylated liposomes, and polymeric nanoparticles are used to facilitate the efficient transport of anti-cancer drugs at the target tumor site. Real-time labeling and monitoring of cancer cells using quantum dots is essential for determining the level of therapy needed for treatment. The drug is targeted to the tumor site either by passive or active means. Passive targeting makes use of the tumor microenvironment and enhanced permeability and retention effect, while active targeting involves the use of ligand-coated nanoparticles. Nanotechnology is being used to diagnose the early stage of cancer by detecting cancer-specific biomarkers using tumor imaging. The implication of nanotechnology in cancer therapy employs photoinduced nanosensitizers, reverse multidrug resistance, and enabling efficient delivery of CRISPR/Cas9 and RNA molecules for therapeutic applications. However, despite recent advancements in nano-oncology, there is a need to delve deeper into the domain of designing and applying nanoparticles for improved cancer diagnostics.

Schlagwörter

Stichwörter der Autor:innen

biomarkercancerdrug resistancenanoformulationnanoimagingnanotechnology

Autor:innen und Institutionen

  • Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
  • Department of Botany, Institute of Science, Banaras Hindu University, Varanasi 221005, India.
  • Department of Oral and Maxillofacial Surgery, Faculty of Dental Sciences, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
  • Department of Agriculture Biotechnology, National Agri-Food Biotechnology Institute, Sahibzada Ajit Singh Nagar 140306, India.

ORCID-Profile: Nilesh Rai, Prafull Salvi, Santosh Kumar Singh, Vibhav Gautam

Förderung

  • Science and Engineering Research Board
  • University Grants Commission
  • Banaras Hindu University
  • Institution of Eminence Seed Grant
  • Varanasi, India and UGC-BSR Start Up Grant
  • University Grants Commissions

Zitieren

APA

Tiwari, H., Rai, N., Singh, S., Gupta, P., Verma, A., Singh, A. K., Kajal, Salvi, P., Singh, S. K., & Gautam, V. (2023). Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics. Bioengineering, 10(7), 760. https://doi.org/10.3390/bioengineering10070760

Vancouver

Tiwari H, Rai N, Singh S, Gupta P, Verma A, Singh AK, et al. Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics. Bioengineering. 2023;10(7):760. doi:10.3390/bioengineering10070760

BibTeX
@article{Tiwari2023,
  author = {Tiwari, Harshita and Rai, Nilesh and Singh, Swati and Gupta, Priyamvada and Verma, Ashish and Singh, Akhilesh Kumar and Kajal and Salvi, Prafull and Singh, Santosh Kumar and Gautam, Vibhav},
  title = {Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics},
  journal = {Bioengineering},
  year = {2023},
  volume = {10},
  number = {7},
  pages = {760},
  doi = {10.3390/bioengineering10070760}
}
Kostenlos starten →